BioSpace News Archive

Career Advice

Driving Industry-Academia Collaboration with a Translational Research Expert

Are you interested in the practical application of life sciences research? If so, an understanding of translational research is useful to see the vast opportunities to help patients and cure diseases.

September 16, 2020
·
6 min read
·
Porschia Parker-Griffin
Deals

Polyneuron Extends Series A to CHF 36.5 Million with Additional CHF 14 Million

HBM Healthcare Investments joins lead investor Sofinnova Partners and New Enterprise Associates in consortium

September 16, 2020
·
4 min read
Tiziana Life Sciences Plc (“Tiziana” or the “Company”) - Demerger of StemPrintER and Distribution in SpecieProposed capital reduction and notice of General Meeting

Tiziana Life Sciences Plc announces that, following a strategic review of its clinical trial programs and core focus, it intends to demerge its StemPrintER and SPARE genomics-based personalised medicine business into a separate and independent listed company, Accustem Sciences Limited.

September 16, 2020
·
6 min read
Synaffix Sees Competitive Early In Vivo Data from ADCs Based on Proprietary Exatecan Linker-Payload

Synaffix B.V., a biotechnology company enabling antibody-drug conjugates with best-in-class therapeutic index, based on proprietary GlycoConnect™, HydraSpace™ and toxSYN™ technology platforms, announces promising findings from its latest in vivo benchmarking study.

September 16, 2020
·
4 min read
New Clinical Studies show Improved Melanoma Detection by US clinicians with Nevisense

SciBase Holding AB, a leading developer of augmented intelligence-based solutions for skin disorders, announced that both the Journal of the American Academy of Dermatology and SKIN, The Journal of Cutaneous Medicine, have published studies assessing the clinical impact of Nevisense.

September 16, 2020
·
4 min read
Policy

Alligator Bioscience receives patent approval for the drug candidate ATOR-1015

Alligator Bioscience announced that the United States Patent and Trademark Office has issued U.S. Patent No. 10,774,150 which covers compositions of matter directed to Alligator’s bispecific drug candidate ATOR-1015.

September 16, 2020
·
2 min read
Business

Forendo Pharma Appoints Dr Cristina Csimma as Chair of the Board of Directors

Forendo Pharma, a clinical-stage drug development company focusing on novel treatments in women’s health, announced that Dr Cristina Csimma has been appointed as Chair of the Board of Directors.

September 16, 2020
·
3 min read
Deals

Takeda to Divest TachoSil® to Corza Health for €350 Million

Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest its TachoSil® Fibrin Sealant Patch to Corza Health, Inc.

September 16, 2020
·
8 min read
Pharm Country

Applied DNA and Takis Biotech/Evvivax to Launch Clinical Trial for Veterinary Use of Linear COVID-19 Vaccine Candidate

Domestic Feline Companion Animals May Serve as Reservoir for SARS-CoV-2 Infections in Humans

September 16, 2020
·
8 min read
Drug Development

First patient dosed in Europe within the Expansion Cohort of Phase I/II Clinical Study of SEL24/MEN1703 in Acute Myeloid Leukemia

Ryvu Therapeutics announced that the first patient has been treated in Europe for the cohort expansion part of Phase II DIAMOND-01 clinical trial investigating SEL24/MEN1703, a first-in-class, oral dual PIM/FLT3 inhibitor, as single agent in Acute Myeloid Leukemia.

September 16, 2020
·
3 min read